亚宝药业：累计回购公司股份20万股

Core Viewpoint - The company, Yabao Pharmaceutical (stock code: 600351), announced a share buyback program, having repurchased a total of 200,000 shares, which represents 0.03% of its total share capital as of August 31, 2025 [1] Summary by Category - Company Actions - Yabao Pharmaceutical has conducted a share buyback, accumulating 200,000 shares through centralized bidding [1] - Financial Impact - The repurchased shares account for 0.03% of the company's total share capital [1]